Hempstead, NY, United States of America

Michael J Wyle


 

Average Co-Inventor Count = 19.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Rockville Centre, NY (US) (2010)
  • Hempstead, NY (US) (2012 - 2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Michael J. Wyle

Introduction

Michael J. Wyle is an accomplished inventor based in Hempstead, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of protein kinase inhibitors. With a total of 3 patents to his name, Wyle's work is focused on addressing critical health issues.

Latest Patents

Among his latest patents is a groundbreaking invention related to 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors. These compounds are designed to inhibit the IGF-1R enzyme, which plays a crucial role in various hyperproliferative diseases such as cancer, inflammation, psoriasis, and conditions affecting the immune and central nervous systems. The innovative compounds and their pharmaceutically acceptable salts are poised to make a significant impact in the treatment and prevention of these diseases.

Career Highlights

Michael J. Wyle is currently associated with Osi Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical research. His expertise and dedication to innovation have positioned him as a key player in the industry.

Collaborations

Wyle has collaborated with notable colleagues, including Lee Daniel Arnold and Cara Cesario, to further advance his research and development efforts.

Conclusion

Michael J. Wyle's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving health outcomes. His work continues to inspire advancements in the treatment of serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…